146 related articles for article (PubMed ID: 7032159)
1. [Biological properties of synthetic glycopeptides stimulating immunogenesis and nonspecific resistance].
Dzheksenbaev OSh
Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):13-8. PubMed ID: 7032159
[No Abstract] [Full Text] [Related]
2. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
Tsujimoto M
J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
[No Abstract] [Full Text] [Related]
3. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
4. Past, present and future of the synthetic immunoadjuvant MDP and its analogs.
Chedid L; Lederer E
Biochem Pharmacol; 1978; 27(18):2183-6. PubMed ID: 365182
[No Abstract] [Full Text] [Related]
5. Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs.
Saiki I; Uemiya M; Kusama T; Yamamura Y; Azuma I
Microbiol Immunol; 1980; 24(3):265-9. PubMed ID: 6968020
[No Abstract] [Full Text] [Related]
6. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulating peptides.
Werner GH; Floc'h F; Migliore-Samour D; Jollès P
Experientia; 1986 May; 42(5):521-31. PubMed ID: 3519270
[No Abstract] [Full Text] [Related]
9. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.
Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y
Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372
[TBL] [Abstract][Full Text] [Related]
10. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
Masek K; Zaoral M; Jezek J; Straka R
Experientia; 1978 Oct; 34(10):1363-4. PubMed ID: 738426
[No Abstract] [Full Text] [Related]
11. [Adjuvant activity and adjuvant arthritis].
Tanaka A
Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
[No Abstract] [Full Text] [Related]
12. Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs.
Kiso M; Kaneda Y; Okumura H; Hasegawa A; Azuma I; Yamamura Y
Carbohydr Res; 1980 Feb; 79(1):C17-9. PubMed ID: 7357566
[No Abstract] [Full Text] [Related]
13. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
14. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
[No Abstract] [Full Text] [Related]
15. [Natural immunostimulants].
Nikitin AV; Navashin SM
Antibiotiki; 1983 Sep; 28(9):702-16. PubMed ID: 6357066
[No Abstract] [Full Text] [Related]
16. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y
Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186
[TBL] [Abstract][Full Text] [Related]
17. [Immunoadjuvant activities of bacterial cell wall components--with special reference to the effects of administration with various vehicles].
Kinoshita F
Osaka Daigaku Shigaku Zasshi; 1978 Jun; 23(1):141-57. PubMed ID: 397324
[No Abstract] [Full Text] [Related]
18. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Mozes E; Sela M; Chedid L
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of N-acetyl-6-amino- and -6-(acylamino)-6-deoxymuramoyl dipeptides, and their immunoadjuvant activities.
Hasegawa A; Okumura H; Kiso M; Azuma I; Yamamura Y
Carbohydr Res; 1980 Feb; 79(1):C20-3. PubMed ID: 7357567
[No Abstract] [Full Text] [Related]
20. Synthesis of conjugates containing N-acetylmuramyl-L-alanyl-D-isoglutaminyl (MDP). Their use as hapten-carrier systems.
Reichert CM; Carelli C; Jolivet M; Audibert F; Lefrancier P; Chedid L
Mol Immunol; 1980 Mar; 17(3):357-63. PubMed ID: 7442679
[No Abstract] [Full Text] [Related]
[Next] [New Search]
